| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Enliven Therapeutics, Inc. (ELVN) has 10 insiders with recent SEC Form 4 filings, including 0 buys and 14 sells. ELVN is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 890.4K | $40.16M | - | |
| CEO | 875.0K | $39.46M | - | |
| Other | 740.2K | $33.38M | - | |
| 10% | 245.7K | $11.08M | -281,408 | |
| COO | 215.0K | $9.70M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct 1, 2024 | Heyman Richard A.74 | Director | Sell | 518 | $27.54 | $14,264.32 | -0.4% | -13.9% | -23.8% | |
| Sep 30, 2024 | Hohl Benjamin60 | Chief Financial Officer | Sale+OE | 6,250 | $24.61 | $153,828.70 | -100% | -12.3% | -19.9% | |
| Sep 16, 2024 | Heyman Richard A.74 | Director | Sell | 1,270 | $22.41 | $28,458.16 | -1.0% | +5.3% | -17.6% | |
| Aug 29, 2024 | Lyssikatos Joseph P50 | Chief Scientific Officer | Sell | 12,000 | $22.49 | $269,841.39 | -0.6% | +14.4% | -8.8% | |
| Aug 27, 2024 | Hohl Benjamin60 | Chief Financial Officer | Sale+OE | 4,250 | $22.54 | $95,781.83 | -100% | +10.3% | -8.3% | |
| Aug 26, 2024 | Kintz Samuel51 | President And CEO | Sell | 12,000 | $22.89 | $274,718.40 | -1.1% | +8.5% | -11.4% | |
| Aug 15, 2024 | Heyman Richard A.74 | Director | Sell | 1,270 | $23.25 | $29,526.20 | -0.5% | +8.5% | -14.9% | |
| Jul 31, 2024 | Heyman Richard A.74 | Director | Sell | 2,351 | $27.50 | $64,662.54 | -1.5% | +8.1% | -28.7% | |
| Jul 31, 2024 | Lyssikatos Joseph P50 | Chief Scientific Officer | Sell | 3,099 | $27.56 | $85,399.45 | -0.3% | +8.1% | -28.7% | |
| Jul 31, 2024 | Kintz Samuel51 | President And CEO | Sell | 2,270 | $27.56 | $62,555.07 | -0.2% | +8.1% | -28.7% |